Sanderson KM - Search Results

1

Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.

Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G, Skinner DG. Sanderson KM, et al. J Urol. 2006 Nov;176(5):2025-31; discussion 2031-2. doi: 10.1016/j.juro.2006.07.075. J Urol. 2006. PMID: 17070244

2

The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer.

Sanderson KM, Stein JP, Skinner DG. Sanderson KM, et al. Urol Oncol. 2004 May-Jun;22(3):205-11; discussion 212-3. doi: 10.1016/j.urolonc.2004.04.030. Urol Oncol. 2004. PMID: 15271318 Review.

3

The prognostic and staging value of lymph node dissection in the treatment of invasive bladder cancer.

Sanderson KM, Skinner D, Stein JP. Sanderson KM, et al. Nat Clin Pract Urol. 2006 Sep;3(9):485-94. doi: 10.1038/ncpuro0582. Nat Clin Pract Urol. 2006. PMID: 16964190 Review.

4

Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.

Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP. Sanderson KM, et al. J Urol. 2007 Jun;177(6):2088-94. doi: 10.1016/j.juro.2007.01.133. J Urol. 2007. PMID: 17509294

5

New molecular markers for bladder cancer detection.

Quek ML, Sanderson K, Daneshmand S, Stein JP. Quek ML, et al. Curr Opin Urol. 2004 Sep;14(5):259-64. doi: 10.1097/00042307-200409000-00003. Curr Opin Urol. 2004. PMID: 15300145 Review.

6

The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer.

Quek ML, Sanderson KM, Daneshmand S, Stein JP. Quek ML, et al. Among authors: sanderson km. Expert Rev Anticancer Ther. 2004 Dec;4(6):1007-16. doi: 10.1586/14737140.4.6.1007. Expert Rev Anticancer Ther. 2004. PMID: 15606329 Review.

7

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma.

Sanderson K, Scotland R, Lee P, Liu D, Groshen S, Snively J, Sian S, Nichol G, Davis T, Keler T, Yellin M, Weber J. Sanderson K, et al. J Clin Oncol. 2005 Feb 1;23(4):741-50. doi: 10.1200/JCO.2005.01.128. Epub 2004 Dec 21. J Clin Oncol. 2005. PMID: 15613700

8

Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.

Sanderson KM, Rouprêt M. Sanderson KM, et al. BJU Int. 2007 Jul;100(1):11-6. doi: 10.1111/j.1464-410X.2007.06841.x. Epub 2007 Apr 8. BJU Int. 2007. PMID: 17428248 Review.

9

Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.

Rouprêt M, Hupertan V, Sanderson KM, Harmon JD, Cathelineau X, Barret E, Vallancien G, Rozet F. Rouprêt M, et al. Among authors: sanderson km. Urology. 2007 Apr;69(4):656-61. doi: 10.1016/j.urology.2007.01.007. Urology. 2007. PMID: 17445646

10

Laparoscopic distal ureterectomy and anastomosis for management of low-risk upper urinary tract transitional cell carcinoma: preliminary results.

Rouprêt M, Harmon JD, Sanderson KM, Barret E, Cathelineau X, Vallancien G, Rozet F. Rouprêt M, et al. Among authors: sanderson km. BJU Int. 2007 Mar;99(3):623-7. doi: 10.1111/j.1464-410X.2006.06688.x. BJU Int. 2007. PMID: 17407517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page